Immunome
IMNM
IMNM
142 hedge funds and large institutions have $518M invested in Immunome in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 70 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less capital invested
Capital invested by funds: $566M → $518M (-$47.9M)
98% less call options, than puts
Call options by funds: $449K | Put options by funds: $29.1M
Holders
142
Holding in Top 10
3
Calls
$449K
Puts
$29.1M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$21.1M | |
| 3 | +$13.8M | |
| 4 |
BlackRock
New York
|
+$10.3M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$10.2M |
Top Sellers
| 1 | -$9.56M | |
| 2 | -$1.35M | |
| 3 | -$1.14M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$902K |
| 5 |
Goldman Sachs
New York
|
-$541K |
